|
US2020405891A1
|
|
System and methods for implementing a biological fluid treatment device
|
|
US2020397931A1
|
|
Biological fluid treatment systems
|
|
WO2020263745A1
|
|
Systems and methods for implementing treatment of biological fluids
|
|
WO2020061537A1
|
|
Methods and kits for preparing pathogen-inactivated whole blood
|
|
EP3731960A1
|
|
Systems and methods for treating biological fluids
|
|
CA3076497A1
|
|
Compositions and methods for pathogen inactivation of platelets
|
|
EP3589297A1
|
|
Kits and methods for preparing pathogen-inactivated platelet compositions
|
|
US2019321407A1
|
|
Compositions and methods for preparation of red blood cells
|
|
CA3048218A1
|
|
Systems and methods for testing and screening using compound bound substrates
|
|
US2019134095A1
|
|
Compositions and methods for improved nk cell therapies
|
|
CN108697738A
|
|
The system and method for being used to prepare blood platelet
|
|
US2018318348A1
|
|
Plasma compositions and methods of use thereof
|
|
WO2016210374A1
|
|
Cryoprecipitate compositions and methods of preparation thereof
|
|
US2018185484A1
|
|
Preparation and use of platelet products
|
|
EP3215139A1
|
|
Compositions and methods for improved car-t cell therapies
|
|
WO2016057965A1
|
|
Compositions and methods for treating viral hemorrhagic fever
|
|
WO2016014854A1
|
|
Methods for preparing platelet products
|
|
JP2012067126A
|
|
Method and device for removing psoralen from blood products
|
|
EA023596B1
|
|
Methods for treating red blood cell composition for pathogen inactivation
|
|
UA102252C2
|
|
Improved method for extincting undesired side reactions at pathogen inactivation of red blood cells
|
